Tumor regression and induction of anti‐tumor immunity by local chemotherapy of guinea‐pigs bearing a line‐10 hepatocarcinoma
- 20 February 1991
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 47 (4) , 626-632
- https://doi.org/10.1002/ijc.2910470424
Abstract
Local administration of a low dosage of the active cyclophosphamide derivative 4‐hydroperoxy‐cyclophosphamide (4‐HPCY) at the site of antigenic stimulation strongly enhances T‐cell‐mediated immune responses in both mice and guinea‐pigs. Such immunopotentiation is related to functional elimination of suppressor cells from the draining lymph nodes. In the present study we examined the potential immunotherapeutic effects of local cytostatic drug administration in strain‐2 guinea‐pigs bearing a line‐10 hepatocarcinoma. This tumor, when injected intradermally (106 cells) metastasizes within 7 days into the draining lymph node and untreated animals die within 60‐80 days from metastatic growth. In sensitization experiments, using irradiated line‐10 tumor cells, potentiation of delayed‐type hypersensitivity reactivity was observed with local administration of low dosages of 4‐HPCY. Intralesional treatment with increasing dosages of 4‐HPCY, when started 7 days after tumor‐cell inoculation and continued for 3 weeks, resulted in a dose‐dependent regression of the primary tumor. Cure rates of up to 75% were achieved. All cured animals showed strong delayed‐type hypersensitivity reactivity towards line‐10 cells and were resistant to a rechallenge with 106 line‐10 tumor cells. When treatment was started at a very late stage of the disease (day 14) only a small number of animals were cured. However, when local chemotherapy was preceded by one (non‐curative) systemic dose of cyclophosphamide, a 57% cure rate was obtained. Again, all cured animals showed strong delayed‐type hypersensitivity reactivity and protective immunity to line‐10 tumor cells. Tumor immunity was transferable to naive recipients with immune spleen cells and was T‐cell‐dependent. Other cytostatic drugs, selected for local immunopotentiating capacity, notably etoposide (VP16) and cis‐platinum (cis‐Pt) were similarly effective in the local chemotherapy protocol.Keywords
This publication has 28 references indexed in Scilit:
- Enhancing effects of locally administered cytostatic drugs on T effector cell functions in miceInternational Journal of Immunopharmacology, 1990
- Local and Systemic Desensitization Induced by Repeated Epicutaneous Hapten ApplicationJournal of Investigative Dermatology, 1987
- Histological evaluation of immunologically mediated tumor regression of the line 10 guinea pig hepatocarcinomaVirchows Archiv B Cell Pathology Including Molecular Pathology, 1986
- Local Administration of Various Cytostatic Drugs after Subcutaneous Immunization Enhances Delayed‐Type Hypersensitivity Reaction to Sheep Red Blood Cells in MiceScandinavian Journal of Immunology, 1986
- Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells.The Journal of Experimental Medicine, 1984
- Effect of a Single Injection of Cyclophosphamide on Immunization Therapy of Metastases Remaining after Excision of Dermal Primary Tumors in Guinea PigsOncology, 1984
- The Spontaneous Loss of Contact Sensitivity in the Mouse Does Not Require B CellsJournal of Investigative Dermatology, 1982
- In vitro effects of 4-hydroperoxycyclophosphamide on human immunoregulatory T subset function. I. Selective effects on lymphocyte function in T-B cell collaboration.The Journal of Experimental Medicine, 1982
- Augmentation of specific immune response against a syngeneic SV40-induced sarcoma in mice by depletion of suppressor T cells with cyclophosphamideCellular Immunology, 1979
- Enhancement of Dinitrochlorobenzene (DNCB) Contact Sensitization by Cyclophosphamide in the Guinea PigJournal of Investigative Dermatology, 1967